Profil
Derrick Freitag served as the Chief Scientific Officer at Isotechnika, Inc. and Isotechnika Pharma, Inc. from 1996 to 2013.
He also held the same position at Aurinia Pharmaceuticals, Inc. Dr. Freitag earned a doctorate degree from the University of Alberta in 1994.
Ehemalige bekannte Positionen von Derrick Freitag
| Unternehmen | Position | Ende |
|---|---|---|
Isotechnika, Inc.
 Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2013 |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 23.10.2013 |
| AURINIA PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Derrick Freitag
| University of Alberta | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Isotechnika, Inc.
Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | Health Technology |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
